Scaling Peptides Without Shutdowns: How Zero Penny Delivered 17.52x ROAS
Special Ops Team
2 minutes

Scaling Peptides Without Shutdowns: How Zero Penny Delivered 17.52x ROAS

Published on:
November 4, 2025

Scaling Testosterone Offers Without Shutdowns 14.83x ROAS Delivered

We handle multiple ad accounts in the hormone optimization and men’s health space. Despite Meta’s strict ad policies on health claims, we’ve achieved stable scaling with over 14x returns all with zero account bans or ad disapprovals.

The Challenge

Anyone in the testosterone niche knows the struggle:

  • Ads for testosterone products rarely pass review.
  • Accounts get hit for “misleading content."
  • Scaling usually means higher risk of bans.

Instead of going blackhat, we built a compliance first ad structure that allows growth without triggering Meta’s filters.

The Approach

Our strategy focused on four key areas:

  • Compliant messaging frameworks : no exaggerated promises, just performance backed angles that pass review.
  • Lifestyle-first creatives : showing energy, confidence, and results without crossing policy lines.
  • Tight audience segmentation : targeting warm lookalikes and intent based traffic, not broad awareness.
  • Optimized funnel flow : simple, trust driven pages that convert on the first click.

The Results

The results were clear: consistent spend scaling, healthy ROAS across multiple accounts, and no more “ad account disabled” emails every week.


This proves that even in restricted niches like hormone optimization, you can scale profitably if you play by the rules and structure your system right.

Want Similar Results?

If you’re running testosterone or other health optimization offers, our framework is already tested and proven.

Zero bans, no wasted ad spend, just clean delivery and sustainable scaling.Your growth story could be next.  

1-tap message us:
TelegramWhatsApp

0-Penny Case Studies is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Share the blog

Ready When You Are

Take 20 seconds to tell us what you’re working on — we’ll show you how we’d approach it.